HantaWorld tracks verified hantavirus outbreak information and provides plain-English context for readers, researchers and public health observers.
Hantaviruses are rodent-borne viruses that can cause severe disease in humans. In the Americas, infection may lead to hantavirus pulmonary syndrome or hantavirus cardiopulmonary syndrome; in Europe and Asia, some hantaviruses are associated with hemorrhagic fever with renal syndrome.
Hantavirus disease is not one single clinical pattern. Public health agencies commonly distinguish between New World hantaviruses, which are associated with hantavirus pulmonary syndrome, and Old World hantaviruses, which are more often linked to hemorrhagic fever with renal syndrome.
The rodent host and virus type vary by region. HantaWorld separates confirmed cases, suspected cases, monitored contacts and country-level risk signals so that maps do not mix laboratory-confirmed disease with general exposure monitoring.
Most human infections are linked to exposure to infected rodents or contaminated dust, surfaces, urine, droppings, or saliva. Andes virus, found in South America, is the main hantavirus known for documented limited person-to-person transmission through close contact.
Early symptoms can include fever, muscle aches, fatigue, headache and gastrointestinal symptoms. Severe disease may progress to cough, shortness of breath and respiratory distress. Prevention focuses on reducing contact with rodents and safely cleaning areas where rodent contamination may be present.
Early diagnosis can be difficult because initial symptoms overlap with influenza, COVID-19, viral pneumonia, leptospirosis, dengue and other febrile illnesses. There is no specific antiviral cure for hantavirus disease; public health guidance emphasizes early recognition, supportive care and management of respiratory, cardiac or kidney complications.